These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28975366)

  • 1. A double dealing tale of p63: an oncogene or a tumor suppressor.
    Chen Y; Peng Y; Fan S; Li Y; Xiao ZX; Li C
    Cell Mol Life Sci; 2018 Mar; 75(6):965-973. PubMed ID: 28975366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
    Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
    J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis.
    Geddert H; Kiel S; Heep HJ; Gabbert HE; Sarbia M
    Hum Pathol; 2003 Sep; 34(9):850-6. PubMed ID: 14562279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb development.
    Monti P; Ciribilli Y; Foggetti G; Menichini P; Bisio A; Cappato S; Inga A; Divizia MT; Lerone M; Bocciardi R; Fronza G
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31789342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAp63 induces senescence and suppresses tumorigenesis in vivo.
    Guo X; Keyes WM; Papazoglu C; Zuber J; Li W; Lowe SW; Vogel H; Mills AA
    Nat Cell Biol; 2009 Dec; 11(12):1451-7. PubMed ID: 19898465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.
    Helton ES; Zhu J; Chen X
    J Biol Chem; 2006 Feb; 281(5):2533-42. PubMed ID: 16319057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63.
    Helton ES; Zhang J; Chen X
    Oncogene; 2008 May; 27(20):2843-50. PubMed ID: 18037962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer.
    Tucci P; Agostini M; Grespi F; Markert EK; Terrinoni A; Vousden KH; Muller PA; Dötsch V; Kehrloesser S; Sayan BS; Giaccone G; Lowe SW; Takahashi N; Vandenabeele P; Knight RA; Levine AJ; Melino G
    Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15312-7. PubMed ID: 22949650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent alteration of p63 expression in human primary bladder carcinomas.
    Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
    Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications.
    Maruya S; Kies MS; Williams M; Myers JN; Weber RS; Batsakis JG; El-Naggar AK
    Hum Pathol; 2005 Jul; 36(7):821-7. PubMed ID: 16084953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
    Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
    PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.
    Abbas HA; Bui NHB; Rajapakshe K; Wong J; Gunaratne P; Tsai KY; Coarfa C; Flores ER
    Cancer Res; 2018 Jan; 78(2):451-462. PubMed ID: 29180475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One, two, three--p53, p63, p73 and chemosensitivity.
    Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
    Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-binding and transactivation activities are essential for TAp63 protein degradation.
    Ying H; Chang DL; Zheng H; McKeon F; Xiao ZX
    Mol Cell Biol; 2005 Jul; 25(14):6154-64. PubMed ID: 15988026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.
    Mitani Y; Li J; Weber RS; Lippman SL; Flores ER; Caulin C; El-Naggar AK
    Am J Pathol; 2011 Jul; 179(1):391-9. PubMed ID: 21703418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p63 regulates proliferation and differentiation of developmentally mature keratinocytes.
    Truong AB; Kretz M; Ridky TW; Kimmel R; Khavari PA
    Genes Dev; 2006 Nov; 20(22):3185-97. PubMed ID: 17114587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.